Press release
Dexcom Expands AID Partnership Into The Netherlands
The world’s most connected continuous glucose monitoring system‡, Dexcom G6, now connects with the Omnipod® 5 Automated Insulin Delivery (AID) System in The
About this update from Dexcom, Inc.
[{"type":"text","content":"\n\nThe world’s most connected continuous glucose monitoring system‡, Dexcom G6, now connects with the Omnipod® 5 Automated Insulin Delivery (AID) System in The Netherlands.\n\n\n\n EDINBURGH, Scotland--(BUSINESS WIRE)--\nDexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, today announced that people living with Type 1 diabetes in the Netherlands will be able to use a new tubeless Hybrid Closed Loop system (HCL) the Omnipod® 5 integrated with the Dexcom G6 Continuous Glucose Monitor (CGM), for an easier1-3 diabetes management experience. In the Netherlands, 100,000 people have type 1 diabetes, with an estimated 10,000 children affected*, making it the most common autoimmune disease among children after asthma 4. Type 1 diabetes can be challenging for anyone to manage and live with, but for children with Type 1, and their families, everyday activities such as exercising, eating, and swimming can be even more challenging. The Omnipod® 5 tubeless insulin pump integrated with the Dexcom G6 CGM can simplify their lives by offering easier1-2,4 diabetes management whilst allowing families, friends, and carers to remotely check glucose levels with the unique to Dexcom ‘Follow’ app||.\n\n\nResearch2 published in Diabetes Care shows that use of this Hybrid Closed Loop system (HCL) significantly increased time in range (+11.5%) and reduced HbA1c and time in hypoglycemia (","length":1853,"tagName":"div"}]